Quick Summary
Covering the latest research from top Wall Street investment banks

Goldman Sachs maintains a Buy rating on Kweichow Moutai and raises the target price to Rmb1,667

Institution
Goldman Sachs
Date
2026-07-20
Authors
Leaf Liu, Christina Liu, Valerie Zhou
Company
Kweichow Moutai
Ticker
600519.SS
Industry
China Consumer Staples / China Spirits
Rating
Buy
BullishLow confidenceGoldman Sachs reiterates Buy, raises the 12-month target price, and views the July 2026 Feitian Moutai price hike as evidence of pricing power, resilient demand and likely earnings accretion.
AuthorsLeaf Liu, Christina Liu, Valerie Zhou
Target priceRmb1,667.00
Asset classesEquity
Business segmentsFeitian Moutai、Moutai spirit、Series spirits、i-Moutai direct sales、Wholesale channels
Research firm divisions/subsidiariesGoldman Sachs(Other)、Goldman Sachs(Asia) L.L.C.(Other)

AI summary card

Goldman Sachs maintains a Buy rating on Kweichow Moutai and raises the target price to Rmb1,667

The report believes that the second price increase in 2026 for Feitian Moutai's ex-factory price and suggested retail price in July further reinforces Kweichow Moutai's pricing power and will provide incremental contribution to earnings in 2H26 and 2027.

Rating: Buy; 12-month target price: Rmb1,667; current price: Rmb1,253; expected upside: 33.0%.
Kweichow Moutai600519.SSFeitian Moutai price hikeBuy ratingChinese baijiuPricing poweri-Moutai
  • The ex-factory price of Feitian Moutai 53%vol 500ml 2026 edition was raised by Rmb100 per bottle to Rmb1,369 per bottle, up 7.9%, mainly covering wholesale channels.
  • The suggested retail price of Feitian Moutai on the i-Moutai platform was raised by Rmb100 per bottle to Rmb1,639 per bottle, up 6.5%, mainly covering direct-sales channels.
  • Goldman Sachs estimates that this price hike will contribute about 1.2% and 1.6% incremental growth to 2026 sales and earnings, respectively, and bring more than about 3% and 4% uplift to sales and earnings in 2027.
  • Goldman Sachs raised its 12-month target price from Rmb1,616 to Rmb1,667 and maintained a Buy rating, implying 33.0% upside from the current price of Rmb1,253.

Report interpretation

Overview

This report focuses on Kweichow Moutai's second Feitian Moutai price hike in July 2026. On July 17, the company announced that starting July 18 it would raise Feitian Moutai prices: the ex-factory price of 500ml Feitian Moutai increased from Rmb1,269/bottle to Rmb1,369/bottle, and the i-Moutai suggested retail price increased from Rmb1,539/bottle to Rmb1,639/bottle. Goldman Sachs believes this continues Moutai's pace of market-oriented reform and reflects the company's pricing power amid resilient demand, stable wholesale prices, and improving channel feedback.

Core views

Goldman Sachs' core views are: first, two price hikes within one year are more frequent than Moutai's historical pattern of one increase every several years, reflecting management's more proactive market-oriented pricing strategy; second, after the March price hike, market feedback was positive and wholesale prices remained stable, and the July increase should help support wholesale prices and channel profitability ahead of the Mid-Autumn Festival; third, the price hike will contribute more visibly to earnings in 2H26 and will accelerate revenue and earnings growth in 2027; fourth, Moutai remains attractive thanks to its differentiated brand positioning, stable consumer demand, ability to gain market share through cycles, and relatively high dividend yield.

Analysis framework

The report uses a combination of price-change decomposition, channel volume and price estimation, earnings forecast revisions, and valuation multiple analysis. Goldman Sachs separately estimates the impact of the price hike on wholesale channels and direct/i-Moutai channels, and raises Moutai spirit ASP by 1% in 2026 and by 3% in 2027-2028E, while broadly keeping volume forecasts and series spirits forecasts unchanged.

Methodology notes

  • Valuation methodsP/E multiple valuation

    The target price is based on 2027E P/E and discounted back to mid-2027

    Goldman Sachs' 12-month target price of Rmb1,667 is based on 23.4x 2027E P/E and discounted back to mid-2027 using an 8.5% cost of equity; the target P/E references the company's average P/E over the full 2012-2023 cycle.

  • earnings_modelchannel price hike contribution analysis

    Estimate the incremental contribution of the price hike to revenue and earnings by channel

    The report applies about 30% pro-rata for wholesale channels and about 40% pro-rata for direct-sales channels, estimating that this round of price hikes will contribute 1.2% to 2026 sales and 1.6% to EPS.

  • factor_profileGoldman Sachs Factor Profile

    Compare stock characteristics across growth, financial returns, valuation multiples, and composite indicators

    GS Factor Profile compares the stock with the covered market and industry peers, converting metrics such as forward sales, EBITDA, EPS, ROE, ROCE, CROCI, P/E, P/B, dividend, and EV-related multiples into percentiles.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Kweichow Moutai / 600519.SS
    subject_company_equity
    Strengths
    Strong differentiated brand positioning; Feitian Moutai has scarcity and pricing power; retail demand on the i-Moutai platform has shown resilience from 2Q26 to date; dividend yield is relatively high at 4.2%/4.6% for 2026E/2027E, respectively.
    Weaknesses
    Expected revenue growth in 2Q26 is only about 1%, and industry demand recovery is still not broad enough; capacity constraints and a slower-than-expected macro recovery may limit growth.
    Comparison
    The report compares 600519.SS with Asia ex Japan Coverage and China Consumer Staples under the GS Factor Profile and assigns a relative rating within China consumer coverage.
    Risks
    Regulatory changes such as higher consumption tax, environmental issues, a slower-than-expected macroeconomic recovery, capacity constraints, and pressure on valuation multiples from U.S. interest rate fluctuations.
  • Feitian Moutai 53%vol 500ml
    key_product_price_driver
    Strengths
    After two price hikes within the year, the ex-factory price and suggested retail price are up 17% and 9%, respectively, versus 2025, demonstrating the pricing power of the core flagship product.
    Weaknesses
    The effectiveness of the price hike depends on channel acceptance, wholesale price stability, and festival demand follow-through.
    Comparison
    Compared with the historical pattern of one price hike every several years, this year's price hike cadence is more frequent; prices in both wholesale and direct-sales channels for 500ml Feitian Moutai were raised.
    Risks
    If end demand weakens or wholesale prices fall, the price increase may pressure transaction volume and channel inventory health.

Key data

  • 12-month target priceRmb1,667The previous target price was Rmb1,616.
  • Current priceRmb1,253Price disclosed in the report.
  • Expected upside33.0%Based on the target price and current price.
  • 500ml Feitian Moutai ex-factory price increaseRmb1,269/瓶至Rmb1,369/瓶Up 7.9%, an increase of Rmb100 per bottle, mainly covering wholesale channels.
  • 500ml Feitian Moutai i-Moutai suggested retail price increaseRmb1,539/瓶至Rmb1,639/瓶Up 6.5%, an increase of Rmb100 per bottle, mainly covering direct-sales channels.
  • 1L Feitian Moutai suggested retail price increaseRmb3,119/瓶至Rmb3,269/瓶Up 4.8%, an increase of Rmb150 per bottle.
  • Cumulative impact of 2026 price hikes出厂价+17%;建议零售价+9%Relative to 2025, reflecting changes after the two price hikes on March 31 and July 18.
  • Contribution of this price hike to 2026 sales and earnings销售额+1.2%;盈利+1.6%Goldman Sachs estimate.
  • Forecast revenue and net profit growth for 2026销售额+3.9%;净利润+3.1% yoyGoldman Sachs revised forecast.
  • Forecast revenue and net profit growth for 2027销售额+8%;净利润+9%Goldman Sachs expects growth to accelerate in 2027.
  • Valuation2026E/2027E P/E为19x/17xTrading valuation description in the report.
  • Dividend yield2026E 4.2%;2027E 4.6%Goldman Sachs believes the dividend yield provides support.
  • Market capitalizationRmb1.6tr / $232.3bnReport Key Data.
  • Enterprise valueRmb1.4tr / $210.4bnReport Key Data.

Impact & implications

The investment implication of this round of price hikes is that Kweichow Moutai still possesses strong brand premium and channel pricing power even as demand in the baijiu industry has yet to fully recover. If wholesale prices remain stable and i-Moutai demand stays resilient, the price hike will lift ASP and drive earnings release in 2H26, while also providing additional support at a higher base for the recovery in revenue and profit growth in 2027. For the stock, the higher target price and continued Buy rating reinforce Goldman Sachs' positive view of its through-cycle resilience and market share gains.

Risks

  • Potential regulatory changes such as higher consumption tax rates.
  • Environmental pollution risk.
  • Macroeconomic recovery slower than expected.
  • Capacity constraints.
  • U.S. rate hikes or greater interest rate volatility, as Moutai's P/E is negatively correlated with the U.S. 10-year Treasury yield.

What to watch

  • Whether wholesale prices for boxed and loose-bottle Feitian Moutai after the July 18 price hike can remain sustainably stable at a higher level.
  • Changes in channel inventory, wholesale prices, and end-demand sell-through ahead of the Mid-Autumn Festival.
  • Changes in active trading users, bottles purchased, and the share of direct sales on the i-Moutai platform.
  • The actual realization of the price hike's impact on revenue, ASP, and EPS in 2H26.
  • Whether 2027 revenue and net profit growth accelerate to about 8% and 9% as Goldman Sachs expects.
  • The impact of consumption tax, macro demand, and the U.S. interest-rate environment on valuation.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins